Aspect Biosystems secures $115M Series B to advance bioprinted tissue therapeutics, accelerating development of functional ...

A Vancouver life sciences firm is printing loads of venture capital, as well as organic tissues. Aspect Biosystems Ltd. has ...

Now, Aspect Biosystems is kicking off 2025 with a bang: it just raised $US115 million in Series B funding, led by American ...

Gain both academic and commercial perspectives on specific applications of biomaterials in personalized healthcare including orthopedics, wound care, and regenerative engineering ... quality ...

(“Celularity” or the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced that on November ...

UA produces human-derived microparticles for application in biomedicine.

A recent review is transforming the landscape of craniomaxillofacial bone regeneration with the introduction of personalized ...

From vitamin D to stem cells, the Alumni Research Foundation has licensed discoveries and supported campus activities.

As an essential component of the human body, collagen is often hailed as the most abundant protein in our system. This fibrous, yet flexible, molecule plays a pivotal role in supporting the structure ...

Emerging trends in life sciences and biotechnology for 2025 include AI-driven drug discovery, synthetic biology, and ...